These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24963113)

  • 1. Patient preferences for noninsulin diabetes medications: a systematic review.
    Purnell TS; Joy S; Little E; Bridges JF; Maruthur N
    Diabetes Care; 2014 Jul; 37(7):2055-62. PubMed ID: 24963113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for the treatment of type 2 diabetes: a scoping review.
    Joy SM; Little E; Maruthur NM; Purnell TS; Bridges JF
    Pharmacoeconomics; 2013 Oct; 31(10):877-92. PubMed ID: 24081453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences.
    Mohamed AF; Zhang J; Johnson FR; Lomon ID; Malvolti E; Townsend R; Ostgren CJ; Parhofer KG
    Diabetes Metab; 2013 Oct; 39(5):397-403. PubMed ID: 23880594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.
    Gelhorn HL; Stringer SM; Brooks A; Thompson C; Monz BU; Boye KS; Hach T; Lund SS; Palencia R
    Diabetes Obes Metab; 2013 Sep; 15(9):802-9. PubMed ID: 23464623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for diabetes treatment attributes and drug classes.
    Flood EM; Bell KF; de la Cruz MC; Ginchereau-Sowell FM
    Curr Med Res Opin; 2017 Feb; 33(2):261-268. PubMed ID: 27779433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.
    Donnan JR; Johnston K; Chibrikov E; Marra CA; Aubrey-Bassler K; Najafzadeh M; Nguyen H; Gamble JM
    Can J Diabetes; 2020 Feb; 44(1):6-13. PubMed ID: 31311729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
    Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
    Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patients' preferences in the medicamentous treatment of diabetes mellitus type 2: A systematic classification and meta-comparison of patient preference studies].
    Mühlbacher AC; Kaczynski A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):452-66. PubMed ID: 25687713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.
    Janssen EM; Hauber AB; Bridges JFP
    Value Health; 2018 Jan; 21(1):59-68. PubMed ID: 29304942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
    Bolen S; Feldman L; Vassy J; Wilson L; Yeh HC; Marinopoulos S; Wiley C; Selvin E; Wilson R; Bass EB; Brancati FL
    Ann Intern Med; 2007 Sep; 147(6):386-99. PubMed ID: 17638715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments.
    Sain N; Willems D; Charokopou M; Hiligsmann M
    Curr Med Res Opin; 2020 Aug; 36(8):1257-1275. PubMed ID: 32468865
    [No Abstract]   [Full Text] [Related]  

  • 14. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S; Rose J; Hamrosi KK; Swain D
    BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment.
    Ozdemir S; Baid D; Verghese NR; Lam AY; Lee PC; Lim AY; Zhu L; Ganguly S; Finkelstein EA; Goh SY
    Value Health; 2020 Jul; 23(7):842-850. PubMed ID: 32762985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment.
    Mühlbacher AC; Sadler A; Juhnke C
    Eur J Health Econ; 2021 Apr; 22(3):425-443. PubMed ID: 33587221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments.
    Diks ME; Hiligsmann M; van der Putten IM
    BMC Infect Dis; 2021 Aug; 21(1):879. PubMed ID: 34454441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.